Table 3. Antibiotic resistance rates of ESBL positive Escherichia coli and Klebsiella species.
| Antibiotic | ESBL (+) (n=66) | ESBL (−) (n=112) | p-value |
|---|---|---|---|
| AMP | 63 (95.5) | 45 (40.2) | <0.001 |
| AMC | 53 (80.3) | 26 (23.2) | <0.001 |
| CRO | 66 (100.0) | 1 (0.9) | <0.001 |
| CXM | 66 (100.0) | 13 (11.6) | <0.001 |
| FEP | 66 (100.0) | 2 (1.8) | <0.001 |
| CAZ | 66 (100.0) | 0 (0.0) | <0.001 |
| IMP | 0 (0.0) | 0 (0.0) | - |
| MEM | 0 (0.0) | 0 (0.0) | - |
| TM-SXT | 36 (54.5) | 21 (18.8) | <0.001 |
| FF | 4 (6.1) | 1 (0.9) | >0.05 |
| TZP | 24 (36.4) | 9 (8.0) | <0.001 |
| CIP | 50 (75.8) | 25 (22.3) | <0.001 |
| LEV | 49 (74.2) | 24 (21.4) | <0.001 |
| GEN | 20 (30.3) | 9 (8.0) | <0.001 |
| AK | 14 (21.2) | 6 (5.4) | <0.001 |
| F | 9 (13.6) | 6 (5.4) | >0.05 |
Values are presented as number (%).
ESBL, extended-spectrum β-lactamase; AMP, ampicillin; AMC, amoxicillin/clavulanate; CRO, ceftriaxone; CXM, cefuroxim; FEP, cefepime; CAZ, ceftazidime; IMP, imipenem; MEM, meropenem; TM-SXT, trimethoprim/sulfamethoxazole; FF, fosfomycin; TZP, piperacillin tazobactam; CIP, ciprofloxacin; LEV, levofloxacin; GEN, gentamicin; AK, amikacin; F, nitrofurantoin.